Abstract
Hepatocellular carcinoma (HCC) is a highly malignant tumor with a poor prognosis and an annual incidence of between 250,000 and 1.2 million cases in high risk areas, such as Southeast Asia, coastal areas of mainland China, and sub-Saharan Africa. Worldwide, it is the seventh most common cancer with the highest incidence of adult malignancy in areas endemic for then hepatitis B virus. From a clinical point of view, the number of HCC cases in Switzerland is expected to possibly increase, due to the increasing number of patients with chronic hepatitis C. The only established treatment to cure the HCC involves hepatic resection or, in selected cases, transplantation. However, the success of these operations is frequently limited due to the often-advanced stage of the tumor at the time of diagnosis. Recent advances in techniques of liver surgery, better preoperative imaging methods and therefore better patient selection have helped to lower mortality and morbidity after hepatic resection. The most frequently used imaging methods today, CT-scan and dynamic CT-scan, may be replaced by the MRI in the near future because of it's more detailed and more sensitive image of liver tumours. A still unresolved problem is the possibly life-threatening postoperative liver insufficiency caused by poor or insufficient liver remnant tissue which may occur after even limited liver resection especially in cirrhotic livers. A prevention of this problem would require a reliable preoperative assessment of the functional capacity of the liver remnant. But these functional assessments are still not satisfactory although the aminopyrin breathing test and galactose eliminating capacity test achieve remarkably good results. The clinical experience of important series of liver resection reported in this issue of Swiss Surgery for HCC from Switzerland, liver resection for HCC in cirrhotic patients from China as well as liver resection for cholangiocellular carcinomas demonstrate that the surgical procedures performed by experts today have a low mortality and morbidity rate and achieve quite remarkable long term survival results. As surgeons and physicians alike we are therefore encouraged today to resect these HCC whenever technically possible and whenever the clinical condition of the patients allow these operations.
EUVIMED